4//SEC Filing
FRISSORA MARK P 4
Accession 0001193805-25-000608
CIK 0001575142other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 9:13 PM ET
Size
16.3 KB
Accession
0001193805-25-000608
Insider Transaction Report
Form 4
FRISSORA MARK P
Director
Transactions
- Award
Series D Convertible Preferred Stock
2025-03-15$10.45/sh+479$5,006→ 4,571 totalFrom: 2025-09-15→ Common Stock (47,900 underlying) - Purchase
Series D Convertible Preferred Stock
2025-04-09$7.52/sh+39,868$299,807→ 44,439 totalFrom: 2025-10-09→ Common Stock (3,986,800 underlying) - Purchase
Option to Purchase Common Stock
2025-04-09+1→ 1 totalExercise: $10.00From: 2028-04-09Exp: 2035-04-09→ Common Stock (500,000 underlying) - Award
Series D Convertible Preferred Stock
2025-04-15$9.99/sh+501$5,005→ 44,940 totalFrom: 2025-10-15→ Common Stock (50,100 underlying) - Award
Series D Convertible Preferred Stock
2025-02-15$11.00/sh+455$5,005→ 4,092 totalFrom: 2025-08-15→ Common Stock (45,500 underlying)
Footnotes (6)
- [F1]The Reporting Person's shares of Series D Convertible Preferred Stock, par value $0.0001 per share, are convertible into shares of common stock, par value $0.0001 per share, at a ratio of 100 shares of common stock for each share of Series D Convertible Preferred Stock, subject to a 10% beneficial ownership limitation. No shares of Series D Convertible Preferred Stock may be converted until six months after the date of issuance, except in the case of liquidation, whereupon the conversion will occur immediately. Each share of Series D Convertible Preferred Stock outstanding at the time of a meeting of stockholders or a solicitation of consent is entitled to 100 votes on matters of the Issuer, without regard to the beneficial ownership limitation. The right to convert does not expire.
- [F2]Represents shares of Series D Convertible Preferred Stock issued as compensation for board services based on a closing price per share of the Issuer's common stock of $0.1100 on February 14, 2025, times 100.
- [F3]Represents shares of Series D Convertible Preferred Stock issued as compensation for board services based on a closing price per share of the Issuer's common stock of $0.1045 on March 14, 2025, times 100.
- [F4]The price per share is based on the average closing price of the Issuer's common stock for the five days prior to the transaction date, less a 20% discount, times 100.
- [F5]The option to purchase 500,000 shares of the Issuer's common stock was granted to the Reporting Person in connection with the Preferred D Stock Purchase Agreement, dated April 9, 2025, between the Issuer and the Reporting Person. No additional consideration was paid to the Issuer in exchange for such option beyond the consideration paid in exchange for the Series D Convertible Preferred Stock.
- [F6]Represents shares of Series D Convertible Preferred Stock issued as compensation for board services based on a closing price per share of the Issuer's common stock of $0.0999 on April 15, 2025, times 100.
Documents
Issuer
BIOADAPTIVES, INC.
CIK 0001575142
Entity typeother
Related Parties
1- filerCIK 0001239786
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 9:13 PM ET
- Size
- 16.3 KB